Cargando…
COVID-19 and therapeutic drugs repurposing in hand: The need for collaborative efforts
The novel pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible to cause coronavirus disease-2019 (COVID-19). It is a global pandemic disease and has reached a new dimension with a higher death ratio. On 2 June 2020, World Health Organization (WHO) data showed more tha...
Autores principales: | Khan, Z., Karataş, Y., Ceylan, A.F., Rahman, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293532/ http://dx.doi.org/10.1016/j.phclin.2020.06.003 |
Ejemplares similares
-
Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action
por: Khan, Zakir, et al.
Publicado: (2020) -
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
por: Alam, Safaet, et al.
Publicado: (2021) -
Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
por: Chatterjee, Bhaswati, et al.
Publicado: (2022) -
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
por: Raghav, Pawan Kumar, et al.
Publicado: (2023) -
Text Mining and Data Modeling of Karyotypes to aid in Drug Repurposing Efforts
por: Abrams, Zachary B., et al.
Publicado: (2015)